CBIO

Crescent Biopharma
CBIO

Overview Fund Trends Analyst Outlook Journalist POV

27 hedge funds and large institutions have $93M invested in Crescent Biopharma in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

60% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 10

Holders
27
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.36M
2
+$388K
3
+$160K
4
SIM
Spark Investment Management
New York
+$136K
5
ARTA
A.R.T. Advisors
New York
+$97K

Top Sellers

1
-$1.07M
2
-$510K
3
-$428K
4
PP
Paloma Partners
Connecticut
-$291K
5
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
-$194K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$59.5M
2
$18.1M
3
$6.37M
4
$3.28M
5
$1.41M
6
$1.04M
7
$708K
8
$663K
9
$388K
10
$329K
11
$209K
12
$160K
13
$158K
14
$152K
15
$136K
16
$97K
17
$88K
18
$74K
19
$41K
20
$37K
21
$35K
22
$9K
23
$1.3K
24
$1K
25
$1K
1
2